An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.

MLA

VanBlargan, Laura A., et al. “An Infectious SARS-CoV-2 B.1.1.529 Omicron Virus Escapes Neutralization by Therapeutic Monoclonal Antibodies.” Nature Medicine, vol. 28, no. 3, Mar. 2022, pp. 490–95. EBSCOhost, https://doi.org/10.1038/s41591-021-01678-y.

APA

VanBlargan, L. A., Errico, J. M., Halfmann, P. J., Zost, S. J., Crowe, J. E., Jr, Purcell, L. A., Kawaoka, Y., Corti, D., Fremont, D. H., & Diamond, M. S. (2022). An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nature Medicine, 28(3), 490–495. https://doi.org/10.1038/s41591-021-01678-y

Chicago

VanBlargan, Laura A, John M Errico, Peter J Halfmann, Seth J Zost, James E Crowe Jr, Lisa A Purcell, Yoshihiro Kawaoka, Davide Corti, Daved H Fremont, and Michael S Diamond. 2022. “An Infectious SARS-CoV-2 B.1.1.529 Omicron Virus Escapes Neutralization by Therapeutic Monoclonal Antibodies.” Nature Medicine 28 (3): 490–95. doi:10.1038/s41591-021-01678-y.